Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols

Introduction. Keratoconus is a progressive corneal disease commonly treated by collagen cross-linking (CXL). Accelerated protocols have recently become common. This study sought to compare the outcomes of accelerated and standard CXL in terms of visual acuity, keratometry, and tomographic parameters...

Full description

Saved in:
Bibliographic Details
Main Authors: Shira Hed, Ran Matlov Kormas, Sagi Shashar, Boris E. Malyugin, Matthew Boyko, Boris Knyazer
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/2659828
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566366500028416
author Shira Hed
Ran Matlov Kormas
Sagi Shashar
Boris E. Malyugin
Matthew Boyko
Boris Knyazer
author_facet Shira Hed
Ran Matlov Kormas
Sagi Shashar
Boris E. Malyugin
Matthew Boyko
Boris Knyazer
author_sort Shira Hed
collection DOAJ
description Introduction. Keratoconus is a progressive corneal disease commonly treated by collagen cross-linking (CXL). Accelerated protocols have recently become common. This study sought to compare the outcomes of accelerated and standard CXL in terms of visual acuity, keratometry, and tomographic parameters in pediatric population. Methods. We retrospectively reviewed the files of pediatric patients who underwent standard and accelerated CXL for keratoconus in our hospital, between October 2014 and March 2018. Changes in uncorrected distance visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), tomographic keratometry parameters (Kmax, Ksteep, Kflat, Kmean), and endothelial density count (EDC) were assessed before and at 6 and 12 months following treatment. The analysis included intergroup and intragroup comparisons. Results. This study included 53 eyes (44 patients). Fourteen eyes were treated with standard CXL (S-CXL, 3 mW/cm2, 30 min), while 39 underwent accelerated CXL (A-CXL, 9 mW/cm2, 10 min). Intergroup comparison found insignificant differences between groups, with the exception of better results for UCDVA in the S-CXL group after 12 months (P = 0.03). In this study, there was no significant difference between the two protocols postoperatively in BCDVA, Kmax, Kmean, pachymetry, or corneal astigmatism. Conclusion. A-CXL is as safe and effective as S-CXL for stabilizing progressive keratoconus in pediatric population. Larger-sample-size studies with a longer follow-up time are required. Considering the long-term results of 9 mW A-CXL and its safety and efficacy profile, it should be preferred to S-CXL for reducing treatment time and improving patients’ comfort.
format Article
id doaj-art-c7996f9f79014f0bb276811f3bb6795c
institution Kabale University
issn 2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-c7996f9f79014f0bb276811f3bb6795c2025-02-03T01:04:26ZengWileyJournal of Ophthalmology2090-00582021-01-01202110.1155/2021/2659828Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two ProtocolsShira Hed0Ran Matlov Kormas1Sagi Shashar2Boris E. Malyugin3Matthew Boyko4Boris Knyazer5Joyce and Irving Goldman Medical SchoolDepartment of OphthalmologyJoyce and Irving Goldman Medical SchoolJoyce and Irving Goldman Medical SchoolDivision of Anesthesiology and Critical CareDepartment of OphthalmologyIntroduction. Keratoconus is a progressive corneal disease commonly treated by collagen cross-linking (CXL). Accelerated protocols have recently become common. This study sought to compare the outcomes of accelerated and standard CXL in terms of visual acuity, keratometry, and tomographic parameters in pediatric population. Methods. We retrospectively reviewed the files of pediatric patients who underwent standard and accelerated CXL for keratoconus in our hospital, between October 2014 and March 2018. Changes in uncorrected distance visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), tomographic keratometry parameters (Kmax, Ksteep, Kflat, Kmean), and endothelial density count (EDC) were assessed before and at 6 and 12 months following treatment. The analysis included intergroup and intragroup comparisons. Results. This study included 53 eyes (44 patients). Fourteen eyes were treated with standard CXL (S-CXL, 3 mW/cm2, 30 min), while 39 underwent accelerated CXL (A-CXL, 9 mW/cm2, 10 min). Intergroup comparison found insignificant differences between groups, with the exception of better results for UCDVA in the S-CXL group after 12 months (P = 0.03). In this study, there was no significant difference between the two protocols postoperatively in BCDVA, Kmax, Kmean, pachymetry, or corneal astigmatism. Conclusion. A-CXL is as safe and effective as S-CXL for stabilizing progressive keratoconus in pediatric population. Larger-sample-size studies with a longer follow-up time are required. Considering the long-term results of 9 mW A-CXL and its safety and efficacy profile, it should be preferred to S-CXL for reducing treatment time and improving patients’ comfort.http://dx.doi.org/10.1155/2021/2659828
spellingShingle Shira Hed
Ran Matlov Kormas
Sagi Shashar
Boris E. Malyugin
Matthew Boyko
Boris Knyazer
Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols
Journal of Ophthalmology
title Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols
title_full Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols
title_fullStr Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols
title_full_unstemmed Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols
title_short Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols
title_sort corneal cross linking as treatment in pediatric keratoconus comparison of two protocols
url http://dx.doi.org/10.1155/2021/2659828
work_keys_str_mv AT shirahed cornealcrosslinkingastreatmentinpediatrickeratoconuscomparisonoftwoprotocols
AT ranmatlovkormas cornealcrosslinkingastreatmentinpediatrickeratoconuscomparisonoftwoprotocols
AT sagishashar cornealcrosslinkingastreatmentinpediatrickeratoconuscomparisonoftwoprotocols
AT borisemalyugin cornealcrosslinkingastreatmentinpediatrickeratoconuscomparisonoftwoprotocols
AT matthewboyko cornealcrosslinkingastreatmentinpediatrickeratoconuscomparisonoftwoprotocols
AT borisknyazer cornealcrosslinkingastreatmentinpediatrickeratoconuscomparisonoftwoprotocols